Home/ Supplements/ Reishi/ LucidiSPORE

LucidiSPORE

product on market Softgel Capsule Natrium Health Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for LucidiSPORE
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
30
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 340.0mg (243 products) 3 studies — no high-quality reviews

Other Ingredients

Gelatin
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take 1 softgel up to 2 times daily.

Warnings & Precautions

Disclaimer: Keep out of reach of children. Do not take this or any other supplement if under the age of 18, pregnant or nursing a baby, or if you have any known or suspected medical conditions, and/or taking prescription drug(s) or OTC medication(s).

Do not take this or any other supplement if under the age of 18, pregnant or nursing a baby, or if you have any known or suspected medical conditions, and/or taking prescription drug(s) or OTC medication(s).

Formulation Notes

Benefits and uses Healthy immune function Stress management support Inflammation support Restful sleep support

Highest triterpene content

Made in the USA with US and imported ingredients

Supercritical Reishi Spore Oil

Immune system and stress defender

Gluten free Non GMO

All natural ingredients

Additional Information

Natrium Health Science Powered by Nature

Storage: Store in a cool and dry place. Keep away from direct sunlight or heat.

USA

Metadata

Product Details

UPC / SKU8 58163 00817 9
DSLD Entry Date2020-08-23
Product TypeNon-Nutrient/Non-Botanical
FormSoftgel Capsule
DSLD ID233387
Data Updated2026-04-11
Research

Research Evidence

6
Research Sources
60
Avg Quality
3
Meta Analysis
3
Rct
B Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Ganoderma lucidum (Reishi mushroom) for cancer treatment
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Ganoderma lucidum (Reishi mushroom) for cancer treatment
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
C Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients
Rct Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 PubMed DOI
C Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Supplementation on Psychological Stress and Selective Fitness Profile Parameters in Female College Students in West Bengal, India
Rct International journal of medicinal mushrooms 2024 PubMed DOI
C Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial
Rct Integrative cancer therapies 2020 PubMed DOI
View all evidence for Reishi →
Compare

Similar Products

View all Reishi products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.